CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Grant or award Director acquired 220 shares (grant or award)
- 4 Grant or award Director acquired 339 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $37.98 ($569,666)
- 4 Open-market sale Director sold 755 shares at $37.19 ($28,078)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 115,415 shares (other)
- 4 Other acquisition Director acquired 84,475 shares (other)
- 4 Open-market sale Director sold 755 shares at $37.12 ($28,026)
- 4 Option exercise Director acquired 711 shares (option exercise)
- 4 Grant or award Director acquired 233 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $37.77 ($566,536)
- 4 Grant or award Director acquired 359 shares (grant or award)
- 4 Grant or award Director acquired 266 shares (grant or award)
Page 13 of 15 · 296 filings